You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Welcome to the Knowledge Base

This respiratory knowledge base hosts in-depth videos on everything from disease and patient management, to research and development. 

Select from videos below to get started. 

Please refer to the full Summaries of Product Characteristics by clicking on the links above.

Ellipta for asthma

Relvar Ellipta Inhaler

Video player requires JavaScript enabled. You can download this video here: http://gskvideo.edgesuite.net/HealthSites/Health/Ireland/HCP/Respiratory/MP4/gskdc-mcm-irl-2017-20963_mccan health_relvar ellipta_d2.mp4 http://gskvideo.edgesuite.net/HealthSites/Health/Ireland/HCP/Respiratory/OGV/gskdc-mcm-irl-2017-20963_mccan health_relvar ellipta_d2.ogv http://gskvideo.edgesuite.net/HealthSites/Health/Ireland/HCP/Respiratory/WEBM/gskdc-mcm-irl-2017-20963_mccan health_relvar ellipta_d2.webm

Why does the inhaler matter in COPD?

Professor Christine Jenkins Clinical professor, University of Sydney Department of Thoaracic Medicine, Concord Hospital Head of Respiratory Trials, The George Institute of Global Health

Experience of Anoro and patient feedback

Video player requires JavaScript enabled. You can download this video here: http://gskvideo.edgesuite.net/HealthSites/Health/Ireland/HCP/MP4/RFUCV009215_GSKDC-DT-MCM-2015-0801_D1.mp4_1300.mp4

Dr Marc Miravitlless Senior Researcher, Pneumology Department. Vall d'Hebron University Hospital, Barcelona, Spain.

Where to use dual bronchodilators in the treatment of COPD

Video player requires JavaScript enabled. You can download this video here: http://gskvideo.edgesuite.net/HealthSites/Health/Ireland/HCP/MP4/RFUCV008915_GSKDC-DT-MCM-2015-0800_D1.mp4_1300.mp4

Dr. Marc Miravitlles Senior Researcher, Pneumology Department. Vall d'Hebron University Hospital, Barcelona, Spain

Benefits of the Ellipta Inhaler

Video player requires JavaScript enabled. You can download this video here: http://gskvideo.edgesuite.net/HealthSites/Health/Ireland/HCP/MP4/RFUCV009315_GSKDC-DT-MCM-2015-0802_D1.mp4_1300.mp4

Dr Marc Miravitlles Senior Researcher, Pneumology Department. Vall d'Hebron University Hospital, Barcelona, Spain Prof. Dave Singh Professor of Clinical Pharmacology and Respiratory Medicine, University of Manchester

Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Anoro, Ellipta, Incruse, Relvar and Seretide are registered trademarks of the GlaxoSmithKline group of companies.